SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$76.02
+4.76 (+6.68%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target -83.7% upside
Low Target $7.31
Average Target $12.40
High Target $17.49
Current Price $76.02
Current
$76.02
Target
$12.40
$7.31 $12.40 avg $17.49
Scenario Analysis
Bear Case
$7.31
-90.4%
Low target
Base Case
$12.40
-83.7%
Avg target
Bull Case
$17.49
+-77.0%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$97.97
-22.4% from high
52-Week Low
$6.96
+992.2% from low
Target vs 52W High
$12.40
-87.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%